Correction of the DNA repair defect in xeroderma pigmentosum group E by injection of a DNA damage-binding protein
- Univ. of California, Berkeley, CA (United States)
- Erasmus Univ., Rotterdam (Netherlands)
Cells from a subset of patients with the DNA-repair-defective disease xeroderma pigmentosum complementation group E (XP-E) are known to lack a DNA damage-binding (DDB) activity. Purified human DDB protein was injected into XP-E cells to test whether the DNA-repair defect in these cells is caused by a defect in DDB activity. Injected DDB protein stimulated DNA repair to normal levels in those strains that lack the DDB activity but did not stimulate repair in cells from other xeroderma pigmentosum groups or in XP-E cells that contain the activity. These results provide direct evidence that defective DDB activity causes the repair defect in a subset of XP-E patients, which in turn establishes a role for this activity in nucleotide-excision repair in vivo.
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 86512
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America, Vol. 91, Issue 9; Other Information: PBD: 26 Apr 1994
- Country of Publication:
- United States
- Language:
- English
Similar Records
Molecular and cellular analysis of the DNA repair defect in a patient in Xeroderma pigmentosum complementation group D who has the clinical features of Xeroderma pigmentosum and Cockayne syndrome
RAD25 (SSL2), the yeast homolog of the human xeroderma pigmentosum group B DNA repair gene, is essential for viability